Compounds > simvastatin
Page last updated: 2024-08-23

simvastatin and Hyperchylomicronemia Late Onset

simvastatin has been researched along with Hyperchylomicronemia Late Onset in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilianou, E; Elisaf, MS; Florentin, M; Liberopoulos, EN; Nikolaou, V; Pitsavos, C; Rizos, CV1
Romaniv, S; Vecka, M; Zák, A; Zeman, M1
Chen, H; Luo, Y; Ren, JY1
Barbir, M; Hunt, BJ; Kehely, A; MacMahon, M; Prescott, RJ; Thompson, GR; Wray, R1
Kayikçioğlu, M; Ozerkan, F; Soydan, I1
Athyros, VG; Kontopoulos, AG; Papageorgiou, AA1

Trials

6 trial(s) available for simvastatin and Hyperchylomicronemia Late Onset

ArticleYear
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
    Lipids, 2017, Volume: 52, Issue:1

    Topics: Adult; Apolipoprotein B-100; Cardiovascular Diseases; Carnitine; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type V; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Simvastatin; Treatment Outcome; Triglycerides; Young Adult

2017
[Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:8

    Topics: Adult; Aged; Anticholesteremic Agents; Clofibric Acid; Drug Therapy, Combination; Female; Fenofibrate; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Simvastatin

2003
[Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].
    Zhonghua xin xue guan bing za zhi, 2005, Volume: 33, Issue:2

    Topics: Drug Therapy, Combination; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Simvastatin

2005
Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
    QJM : monthly journal of the Association of Physicians, 1995, Volume: 88, Issue:6

    Topics: Adolescent; Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Simvastatin; Treatment Outcome; Triglycerides

1995
Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia.
    The American journal of cardiology, 1999, Apr-01, Volume: 83, Issue:7

    Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipids; Male; Middle Aged; Prospective Studies; Simvastatin

1999
Statin-fibrate combinations in patients with combined hyperlipedemia.
    Atherosclerosis, 2001, Volume: 155, Issue:1

    Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Myocardial Infarction; Pravastatin; Simvastatin; Stroke

2001